Show simple item record

Monitoring dosimetric impact of weight loss with kilovoltage (kV) cone beam CT (CBCT) during parotid-sparing IMRT and concurrent chemotherapy.

dc.contributor.authorHo, Kean F
dc.contributor.authorMarchant, Thomas E
dc.contributor.authorMoore, Christopher J
dc.contributor.authorWebster, Gareth J
dc.contributor.authorRowbottom, Carl G
dc.contributor.authorPennington, Hazel
dc.contributor.authorLee, Lip W
dc.contributor.authorYap, Beng K
dc.contributor.authorSykes, Andrew J
dc.contributor.authorSlevin, Nicholas J
dc.date.accessioned2012-03-20T13:02:00Z
dc.date.available2012-03-20T13:02:00Z
dc.date.issued2012-03-01
dc.identifier.citationMonitoring dosimetric impact of weight loss with kilovoltage (kV) cone beam CT (CBCT) during parotid-sparing IMRT and concurrent chemotherapy. 2012, 82 (3):e375-82 Int J Radiat Oncol Biol Physen_GB
dc.identifier.issn1879-355X
dc.identifier.pmid22197229
dc.identifier.doi10.1016/j.ijrobp.2011.07.004
dc.identifier.urihttp://hdl.handle.net/10541/216114
dc.description.abstractParotid-sparing head-and-neck intensity-modulated radiotherapy (IMRT) can reduce long-term xerostomia. However, patients frequently experience weight loss and tumor shrinkage during treatment. We evaluate the use of kilovoltage (kV) cone beam computed tomography (CBCT) for dose monitoring and examine if the dosimetric impact of such changes on the parotid and critical neural structures warrants replanning during treatment.
dc.language.isoenen
dc.rightsArchived with thanks to International journal of radiation oncology, biology, physicsen_GB
dc.subject.meshAdult
dc.subject.meshAged
dc.subject.meshAlgorithms
dc.subject.meshAntineoplastic Agents
dc.subject.meshBrain Stem
dc.subject.meshCarboplatin
dc.subject.meshCarcinoma, Squamous Cell
dc.subject.meshChemoradiotherapy
dc.subject.meshCisplatin
dc.subject.meshCone-Beam Computed Tomography
dc.subject.meshFeasibility Studies
dc.subject.meshFemale
dc.subject.meshHumans
dc.subject.meshLarynx
dc.subject.meshMale
dc.subject.meshMiddle Aged
dc.subject.meshMouth
dc.subject.meshOrgan Sparing Treatments
dc.subject.meshOrgans at Risk
dc.subject.meshOropharyngeal Neoplasms
dc.subject.meshParotid Gland
dc.subject.meshProspective Studies
dc.subject.meshRadiotherapy Dosage
dc.subject.meshRadiotherapy Planning, Computer-Assisted
dc.subject.meshRadiotherapy, Intensity-Modulated
dc.subject.meshSpinal Cord
dc.subject.meshTumor Burden
dc.subject.meshWeight Loss
dc.titleMonitoring dosimetric impact of weight loss with kilovoltage (kV) cone beam CT (CBCT) during parotid-sparing IMRT and concurrent chemotherapy.en
dc.typeArticleen
dc.contributor.departmentAcademic Radiation Oncology, The Christie NHS Foundation Trust, Manchester, UK. hokeanfatt@hotmail.comen_GB
dc.identifier.journalInternational Journal of Radiation Oncology, Biology, Physicsen_GB
html.description.abstractParotid-sparing head-and-neck intensity-modulated radiotherapy (IMRT) can reduce long-term xerostomia. However, patients frequently experience weight loss and tumor shrinkage during treatment. We evaluate the use of kilovoltage (kV) cone beam computed tomography (CBCT) for dose monitoring and examine if the dosimetric impact of such changes on the parotid and critical neural structures warrants replanning during treatment.


Files in this item

This item appears in the following Collection(s)

Show simple item record